Vaxart (VXRT) made a big splash last year, as one of the smaller companies to enter the Covid-19 vaccine race. However, while Vaxart’s Covid-19 vaccine candidate’s oral nature differentiates itself from the pack, the program has yet to reach full fruition and results have been mixed so far. Jefferies’ Kelechi Chikere says the candidate has exhibited some “interesting data but the bar is set high by injectables and much work still needs to be done.” That said, while investors have cottoned on to one opportunity, Chikere says better prospects lie with a different candidate from Vaxart’s pipeline.
https://www.tipranks.com/news/article/vaxart-not-just-a-covid-19-play
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more Vaxart Charts.
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more Vaxart Charts.